Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2003
12/25/2003CA2432864A1 Method for the impedimetric detection of one or more analytes in a sample, and device for use therein
12/24/2003WO2003107249A1 Method for predicting a drug transport capability by abcg2 polymorphisms
12/24/2003WO2003107144A2 Systems and methods for predicting oligonucleotide melting temperatures (tms)
12/24/2003WO2003107006A1 Oxaliplatin anti-resistance agent
12/24/2003WO2003106998A1 Systems and methods for constructing genomic-based phenotypic models
12/24/2003WO2003106974A2 Diagnosis and treatment of chemoresistant tumors
12/24/2003WO2003106972A2 Multiple domain tdf-related compounds and analogs thereof
12/24/2003WO2003106714A1 Compositions and methods for detecting hepatitis b virus
12/24/2003WO2003106712A1 Antisense modulation of ptpn12 expression
12/24/2003WO2003106711A1 Antisense modulation of extracellular-signal regulated kinase-6 expression
12/24/2003WO2003106707A1 Method for detecting increased susceptibility to tumours
12/24/2003WO2003106705A1 In vitro screening of cellular events using 3d cell culture systems
12/24/2003WO2003106704A1 Method for identifying intracellular transport modulators by measuring the expression or activity of neutral sphingomyelinase
12/24/2003WO2003106693A2 Gradient structures interfacing microfluidics and nanofluidics, methods for fabrication and uses thereof
12/24/2003WO2003106692A2 Methods for the identification of all-antigens and their use for cancer therapy and transplantation
12/24/2003WO2003106691A1 POLYPEPTIDES HAVING alpha- H-alpha-AMINO ACID AMIDE RACEMASE ACTIVITY AND NUCLEIC ACIDS ENCODING THE SAME
12/24/2003WO2003106688A1 Glucosyltransferases which clucosylate salicylic acid
12/24/2003WO2003106687A1 Method for enhancing the disease resistance in plants by altering trehalose-6-phosphate levels
12/24/2003WO2003106686A1 Food grade vector comprising psti-spei fragment of pmmh1 plasmid derived from wild-type bacillus
12/24/2003WO2003106685A1 Cell wall mutants for delivery of biologically active compounds
12/24/2003WO2003106684A2 A method for simultaneous production of multiple proteins; vectors and cells for use therein
12/24/2003WO2003106683A1 Novel screening method
12/24/2003WO2003106681A2 Antisense oligonucleotides against pim1
12/24/2003WO2003106679A1 Methods of producing dna and protein libraries
12/24/2003WO2003106677A1 Novel cathepsin l-like cysteine protease originating in pink shrimp
12/24/2003WO2003106675A1 Translation templates and library thereof, proteins synthesized therefrom and protein library, constituents thereof, process for producing the same and method of using the same
12/24/2003WO2003106674A2 Means and methods for regulating gene expression
12/24/2003WO2003106672A2 METHOD FOR UTILIZING THE 5'END OF mRNA FOR CLONING AND ANALYSIS
12/24/2003WO2003106670A1 Recombinant triacylglycerol lipase of arabidopsis thaliana, nucleotide sequences coding for same or corresponding to antisense sequences and uses thereof
12/24/2003WO2003106669A1 Purified pkb ser 473 kinase and uses thereof
12/24/2003WO2003106668A1 Glucose dehydrogenase
12/24/2003WO2003106667A2 Regulation of human subtilase-like serine protease
12/24/2003WO2003106662A1 In vitro fertilisation
12/24/2003WO2003106659A2 Aptamer-toxin molecules and methods for using same
12/24/2003WO2003106658A2 Hybrid vector having a cytomegalovirus enhancer and myeloproliferative sarcoma virus promoter
12/24/2003WO2003106654A2 Xylanases, nucleic adics encoding them and methods for making and using them
12/24/2003WO2003106653A2 Recombinant polynucleotides encoding pro-geldanamycin producing polyketide synthases and accessory proteins, and uses thereof
12/24/2003WO2003106652A2 Method of haplotype-based genetic analysis for determining risk for developing insulin resistance, coronary artery disease and other phenotypes
12/24/2003WO2003106648A2 Compositions and methods relating to breast specific genes and proteins
12/24/2003WO2003106647A2 Antisense modulation of junctional adhesion molecule 3 expression
12/24/2003WO2003106646A2 Antisense modulation of dual specific phosphatase 4 expression
12/24/2003WO2003106645A2 Antisense modulation of smrt expression
12/24/2003WO2003106639A2 Recombination of nucleic acid library members
12/24/2003WO2003106638A2 Methods and cells for improved production of polyketides
12/24/2003WO2003106637A2 Polymeric label molecules
12/24/2003WO2003106636A2 Novel methods for the delivery of polynucleotides to cells
12/24/2003WO2003106633A2 Method to increase isoflavonoid levels in plants and plants producing increased levels of isoflavonoids
12/24/2003WO2003106631A2 Methods and compositions relating to labeled rna molecules that reduce gene expression
12/24/2003WO2003106630A2 Methods and compositions relating to polypeptides with rnase iii domains that mediate rna interference
12/24/2003WO2003106625A2 Hammerhead ribozymes
12/24/2003WO2003106621A2 Anti-igf-i receptor antibody
12/24/2003WO2003106620A2 Nucleic acid sequencing by signal stretching and data integration
12/24/2003WO2003106619A2 Multifunctional polypeptides
12/24/2003WO2003106618A2 Novel cancer therapies
12/24/2003WO2003106616A2 MEMBRANE-ANCHORED beta2 MICROGLOBULIN COVALENTLY LINKED TO MHC CLASS I PEPTIDE EPITOPES
12/24/2003WO2003106499A1 Antibody and inhibitor and transformation method and transformation kit using the same
12/24/2003WO2003106496A1 Antibodies, peptides and vaccines against hiv-1 virus
12/24/2003WO2003106494A1 A human collagen-like protein and the method of producing it
12/24/2003WO2003106491A2 Cell penetrating peptides
12/24/2003WO2003106490A1 A fusion protein comprising a cellulose binding domain
12/24/2003WO2003106488A2 Novel antagonists of cxcr3-binding cxc chemokines
12/24/2003WO2003106487A1 Immunogenic conjugates
12/24/2003WO2003106485A1 Method for the production of protamine
12/24/2003WO2003106484A1 Improved method of producing an aspartic protease in a recombinant host organism
12/24/2003WO2003106483A1 A recombinant anti-enveloped virus peptide and its preparation
12/24/2003WO2003106479A2 Pokeweed antiviral protein polypeptides with antiviral activity
12/24/2003WO2003106476A1 Nucleic acid mediated inhibition of enterococcus infection and cytolysin toxin activity
12/24/2003WO2003106053A1 Methods, systems, and computer program products for simulating biomembranes using coarse grain models
12/24/2003WO2003105900A1 Regulation of secretory phospholipase a2 group iia
12/24/2003WO2003105891A2 Use of hec1 antagonists in the treatment of proliferative disorders and cancer
12/24/2003WO2003105879A1 Compositions and methods for preventing, treating and diagnosing diabetes
12/24/2003WO2003105874A1 Thymic epithelial cells with progenitor capacity
12/24/2003WO2003105782A2 Specificity grafting of a murine antibody onto a human framework
12/24/2003WO2003105778A2 Phosphatidylinositol-4-phosphate 5-kinase, type ii beta inhibitors for inhibiting angiogenesis
12/24/2003WO2003105773A2 Activating mutations of platelet derived growth factor receptor alpha (pdgfra) as diagnostic markers and therapeutic targets:
12/24/2003WO2003105755A2 Antisense modulation of vegf-c expression
12/24/2003WO2003105754A2 Antisense modulation of vegf-b expression
12/24/2003WO2003105753A2 Methods and compositions for grafting functional loops into a protein
12/24/2003WO2003105591A1 Method for identifying fungicidally active compounds
12/24/2003WO2003105578A1 Model animals non-responsive to mycobacteria-origin lipoprotein/lipopeptide
12/24/2003WO2003105577A1 Drosophila transgenic animal models for myotonic dystrophies
12/24/2003WO2003087294A3 Recombining viral vectors for the tetracycline-regulated expression of genes
12/24/2003WO2003083136B1 Method and kit for detecting membrane protein-protein interactions
12/24/2003WO2003083123A3 Improved method for the production of vitamin b12
12/24/2003WO2003083113A3 Growth regulating proteins
12/24/2003WO2003083080A3 Mixed- cell gene therapy
12/24/2003WO2003080844A3 Enhancement of vitamin e content in organisms by enhancing 2-methyl-6-phytyl hydroquinone-methyltransferase activity
12/24/2003WO2003079020A3 Methods and compositions for the identification, assessment, and therapy of small cell lung cancer
12/24/2003WO2003078659A3 Microcapsules with controlable permeability encapsulating a nucleic acid amplification reaction mixture and their use as reaction compartments for parallels reactions
12/24/2003WO2003078458A3 Tap-70, a novel marker for epithelial tumors
12/24/2003WO2003078451A3 Method of isolating binding peptides from a combinatorial phage display library and peptides produced thereby
12/24/2003WO2003075647A3 Method and system for in vivo analysis of developmental processes
12/24/2003WO2003075014A3 Protein-protein interactions in human tumours involving bcmp-7 and bcmp-11
12/24/2003WO2003074721A3 Method for producing riboflavin
12/24/2003WO2003074716A3 Methods for the production of unsaturated fatty acids
12/24/2003WO2003074688A3 Polynucleotides encoding a beta-glucosidase and uses thereof
12/24/2003WO2003072785A3 Fermentation process
12/24/2003WO2003072755A3 Transgenic zebrafish models for thrombosis
12/24/2003WO2003072741A3 Therapeutic regulation of deoxyribonuclease-1-like-3 activity
12/24/2003WO2003070957A3 Plant polypeptide production
1 ... 2345 2346 2347 2348 2349 2350 2351 2352 2353 2354 2355 2356 2357 2358 2359 2360 2361 2362 2363 2364 2365 ... 4023